Omeros (OMER) EBITDA Margin (2010 - 2026)
Omeros (OMER) posted EBITDA Margin of 176.09% for Q1 2026, up 52.48% sequentially from 370.6% in Q2 2022.
Powered by 
Analysis
Omeros (OMER) EBITDA Margin (2010 - 2026) Analysis & Trends
Omeros has reported EBITDA Margin for 14 years, with the latest figure at 176.09% in Q1 2026.
- Quarterly EBITDA Margin changed N/A year-over-year to 176.09% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 389.94% (down 64935.0% YoY) and the FY2020 annual result came in at 212.59%, down 8197.0% from the prior year.
- EBITDA Margin rose to 176.09% in Q1 2026 per OMER's latest filing, from 370.6% in the prior quarter.
- Over five years, EBITDA Margin peaked at 176.09% in Q1 2026 and troughed at 500.94% in Q1 2022.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 37.40% |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 30.15% |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 32.54% |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -562.07% |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 19.06% |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 17.93% |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 19.75% |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -0.36% |
| 10 | Omeros | 1.38 Bn | 1.38 Bn | 27.73 Mn | 0.26% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 0.26% |
| Mar 31, 2026 | -176.09% |
| Jun 30, 2022 | -370.60% |
| Mar 31, 2022 | -500.94% |
| Dec 31, 2021 | -139.04% |
| Sep 30, 2021 | -132.74% |
| Jun 30, 2021 | -158.24% |
| Mar 31, 2021 | -215.04% |
| Dec 31, 2020 | -318.06% |
| Sep 30, 2020 | -97.37% |
| Jun 30, 2020 | -204.58% |
| Mar 31, 2020 | -100.59% |
| Dec 31, 2019 | -70.93% |
| Sep 30, 2019 | -37.18% |
| Jun 30, 2019 | -34.90% |
| Mar 31, 2019 | -88.34% |
| Dec 31, 2018 | -83.91% |
| Sep 30, 2018 | -769.14% |
| Jun 30, 2018 | -1,849.97% |
| Mar 31, 2018 | -1,743.64% |